neoindicate.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: | ||
Meta Tags
| Title | NeoIndicate |
| Description | About NeoIndicate, advancing tools for improved tumor detection, imaging and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.71.232.3 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
neoindicate.com Valuation
|
US$458,308
Last updated: 2023-05-08 23:48:22
neoindicate.com has Semrush global rank of 23,094,317. neoindicate.com has an estimated worth of US$ 458,308, based on its estimated Ads revenue. neoindicate.com receives approximately 52,882 unique visitors each day. Its web server is located in United States, with IP address 198.71.232.3. According to SiteAdvisor, neoindicate.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$458,308 |
| Daily Ads Revenue | US$424 |
| Monthly Ads Revenue | US$12,692 |
| Yearly Ads Revenue | US$152,300 |
| Daily Unique Visitors | 3,526 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| neoindicate.com. | A | 599 | IP: 198.71.232.3 |
| neoindicate.com. | NS | 3600 | NS Record: ns40.domaincontrol.com. |
| neoindicate.com. | NS | 3600 | NS Record: ns39.domaincontrol.com. |
HtmlToTextCheckTime:2023-05-08 23:48:22
| NeoIndicate NeoIndicate NeoIndicate NeoIndicate NeoIndicate NeoIndicate NeoIndicate NeoIndicate Home Platform Technology Publications News Our People Brochure More Home Platform Technology Publications News Our People Brochure Home Platform Technology Publications News Our People Brochure About us Advanced Tools for Improved Tumor Detection Our agents specifically recognize unique biomarkers only present in the tumor microenvironment. Targeted Imaging Agents Each agent is easily modified for tumor diagnosis, fluorescent guided surgery, specific MRI and PET imaging or targeted tumor therapeutics. Tumor Specific Treatment Therapeutics are targeted for brain tumors, melanoma, breast, ovarian, prostate and lung cancer. Video Neo-001 Technology Our team Susann Brady-Kalnay, PhD Susann Brady-Kalnay, PhD Susann Brady-Kalnay, PhD Chief Scientific Officer Ted Gastineau Susann Brady-Kalnay, PhD Susann Brady-Kalnay, PhD Chief Executive Officer Samantha Oblander, PhD Susann Brady-Kalnay, PhD |
HTTP Headers
HTTP/1.1 301 Moved Permanently location: https://neoindicate.com/ Vary: Accept-Encoding Server: DPS/1.12.0 X-SiteId: 2000 Set-Cookie: dps_site_id=2000; path=/ Date: Sat, 30 Oct 2021 22:00:52 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/2 404 content-type: text/html;charset=utf-8 content-length: 964 vary: Accept-Encoding server: DPS/1.12.0 x-siteid: 2000 set-cookie: dps_site_id=2000; path=/; secure date: Sat, 30 Oct 2021 22:00:52 GMT |
neoindicate.com Whois Information
Domain Name: NEOINDICATE.COM Registry Domain ID: 2512086323_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-04-08T16:19:14Z Creation Date: 2020-04-07T18:21:59Z Registry Expiry Date: 2022-04-07T18:21:59Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS39.DOMAINCONTROL.COM Name Server: NS40.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T08:15:56Z <<< |